EUVIMEDEUVIMED entdecken
Crossref

Survey of Clinical Protocols for the Use of 177 Lu-PSMA-617 in the United States

Phillip H Kuo, Matthew F Covington, Daniel J Lee, Terence Z Wong, Neeta Pandit-Taskar

Journal of Nuclear Medicine Technology · 2024-09 · 52 (3) · 208-211

DOI: 10.2967/jnmt.123.266769 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Nuclear Medicine Technology, online erschienen am 13.02.2024. Verfasst von Phillip H Kuo und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medical Imaging, University of Arizona, Tucson, Arizona; pkuo@email.arizona.edu. Hauptthemen laut MEDLINE: Dipeptides, Heterocyclic Compounds, 1-Ring, Lutetium, Clinical Protocols. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 7 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Although guidelines for the use of 177Lu-PSMA-617 published by various organizations are important, they do not include all the essential, practical points necessary for a complete institutional protocol. Therefore, a brief survey was performed to assess key components of the 177Lu-PSMA-617 protocol before, during, and after delivery of therapy. This survey demonstrated the wide variability in many aspects of institutional protocols regarding determination of eligibility for and administration of 177Lu-PSMA-617 therapy. The real-world protocol details provided here from a variety of institutions may help new and established theranostic programs.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

DipeptidesHeterocyclic Compounds, 1-RingLutetiumClinical ProtocolsHumansUnited StatesSurveys and QuestionnairesProstatic NeoplasmsProstate-Specific Antigen

Stichwörter der Autor:innen

PSMAlutetiumprotocolsurveytheranostics

Substanzen

DipeptidesHeterocyclic Compounds, 1-RingLutetiumPluvictoProstate-Specific Antigen

Autor:innen und Institutionen

  • Department of Medical Imaging, University of Arizona, Tucson, Arizona; pkuo@email.arizona.edu.
  • Department of Radiology and Imaging Sciences, University of Utah, Salt Lake City, Utah.
  • Center for Quantitative Cancer Imaging, Huntsman Cancer Institute, Salt Lake City, Utah.
  • Department of Radiology, University of Texas Southwestern Medical Center, Dallas, Texas.
  • Departments of Radiology (Nuclear Medicine and Radiotheranostics) and Medicine (Medical Oncology), Duke Health, Durham, North Carolina.
  • Molecular Imaging and Therapy Service, Department of Radiology, Memorial Sloan Kettering Cancer Center, New York, New York; and.

Zitieren

APA

Kuo, P. H., Covington, M. F., Lee, D. J., Wong, T. Z., & Pandit-Taskar, N. (2024). Survey of Clinical Protocols for the Use of 177 Lu-PSMA-617 in the United States. Journal of Nuclear Medicine Technology, 52(3), 208-211. https://doi.org/10.2967/jnmt.123.266769

Vancouver

Kuo PH, Covington MF, Lee DJ, Wong TZ, Pandit-Taskar N. Survey of Clinical Protocols for the Use of 177 Lu-PSMA-617 in the United States. Journal of Nuclear Medicine Technology. 2024;52(3):208-211. doi:10.2967/jnmt.123.266769

BibTeX
@article{Kuo2024,
  author = {Kuo, Phillip H and Covington, Matthew F and Lee, Daniel J and Wong, Terence Z and Pandit-Taskar, Neeta},
  title = {Survey of Clinical Protocols for the Use of 177 Lu-PSMA-617 in the United States},
  journal = {Journal of Nuclear Medicine Technology},
  year = {2024},
  volume = {52},
  number = {3},
  pages = {208--211},
  doi = {10.2967/jnmt.123.266769}
}
Kostenlos starten →